Showing results (201-210 of 665) with videos related to

Sort By:
Pageof 67
FEBS Letters|February 10, 1992
Up-regulation of the interleukin-6-signal transducing protein (gp130) by interleukin-6 and dexamethasone in HepG2 cellsH Schooltink, H Schmitz-Van de Leur, P C Heinrich, et al.
European Journal of Immunology|May 1, 1988
Induction of rat acute-phase proteins by interleukin 6 in vivoT Geiger, T Andus, J Klapproth, et al.
Clinical Sarcoma Research|April 16, 2019
Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group RegistryJerry W Call, Yu Wang, Denisse Montoya, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 13, 2009
Peripheral intravenous power injection of iodinated contrast media through 22G and 20G cannulas: can high flow rates be achieved safely? A clinical feasibility studyS A Schwab, M Uder, K Anders, et al.
Gut|December 1, 1987
Healthy controls have as much bile reflux as gastric ulcer patientsN E Schindlbeck, C Heinrich, F Stellaard, et al.
The Journal of Biological Chemistry|March 21, 2003
A fusion protein of the gp130 and interleukin-6Ralpha ligand-binding domains acts as a potent interleukin-6 inhibitorCécile Ancey, Andrea Küster, Serge Haan, et al.
The Journal of Biological Chemistry|April 15, 2000
The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130L Terstegen, P Gatsios, J G Bode, et al.
Histopathology|July 19, 2012
Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation studyLeona A Doyle, Dylan Nelson, Michael C Heinrich, et al.
Investigative Radiology|April 1, 1992
Noninvasive liver-iron quantification by computed tomography in iron-overloaded ratsP Nielsen, R Engelhardt, R Fischer, et al.
Archives of Toxicology|January 1, 1991
Bioavailability of bismuth from 205Bi-labelled pharmaceutical oral Bi-preparations in ratsB Dresow, P Nielsen, R Fischer, et al.
Pageof 67